Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Recruiting

AI DeviceMulti-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Sponsor:

Tempus AI

Code:

NCT06911632

Conditions

Pulmonary Hypertension

Interstitial Lung Disease (ILD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ECG-based AI Device - Results Returned to Investigator

Echocardiogram and Right Heart Catheterization

ECG-based AI Device - Results Not Returned to Investigator

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-22. This information was provided to ClinicalTrials.gov by Tempus AI on 2025-12-30.